Lingling Zhu
5PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 24, 2025
Nanodrug Modulates Premetastatic Niche and Suppresses Metastatic Lung Adenocarcinoma via Programmed Cell Death Ligand 1 Blockade and STING Pathway Activation.Xiao Wu, Buyan Li, Haotian Liao
|Jan 23, 2024
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.Jiang Chen, Zohreh Amoozgar, Xin Liu
|Jul 25, 2022
Tumor vessel normalization and immunotherapy in gastric cancer.Xianzhe Yu, Shan He, Jian Shen
|Feb 10, 2022
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy.Yuling Xiao, Jiang Chen, Hui Zhou
|Jul 11, 2021
Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges.Lingling Zhu, Xianzhe Yu, Li Wang
Pageof 1
Frequent Collaborators
3 joint publications
Jiang Chen
2 joint publications
Dan G Duda
1 joint publications
Xianzhe Yu
1 joint publications
Zihan Qu
1 joint publications
Qinghua Zhou
1 joint publications
Hui Zhou
1 joint publications
Xiaodong Zeng
1 joint publications
Jinjun Shi
1 joint publications
Zohreh Amoozgar
1 joint publications
Xin Liu
